Paragangliomas
are benign tumors arising from brachiomeric paraganglia dispersed near or in
the autonomic nervous system extending from the skull bone down to the pelvic floor.(1,2)
Paragangliomas located outside the adrenal
glands are termed extra adrenal
paragangliomas which in turn
are divided into two groups; Group I which is associated with parasympathetic
system and located in the head, neck and anterior mediastinum and thought to
have chemoreceptive function, and Group II that is associated with sympathetic
system and located in the posterior mediastinum and retroperitoneum and
believed to have a function similar to the adrenal medulla.(1-3)
Paragangliomas
of the head and neck include: carotid
body tumors, glomus
jugulare, glomus tympanic
and glomus vagale.(2,4)
Paragangliomas arising from the carotid body are uncommon neoplasms
accounting for 0.5% of all body tumors but compromise 60-70% of head and neck paragangliomas.(5-8)
Carotid
body is a chemoreceptor found in the adventitia of the postero- medial surface
of the common carotid artery bifurcation and is attached by Mayer’s ligament
which carries its blood supply that mostly arises from the external carotid
artery.(7,9,10) Carotid body tumor has high blood flow and
oxygen consumption averaging approximately 0.2 L/g/min.(10)
Macroscopically,
carotid body tumor is a well circumscribed, rubbery and reddish
brown tumor.
Microscopically,
it is characterized by cell
nests (Zellballen)
composed of chief cells (type I) encircled by a thin layer of sustentacular
cells (type II).(3,9,11)
Carotid
body is responsive primarily to hypoxia and to a lesser extent to acidosis and
hypercarbia and once stimulated it causes increase in the heart rate, blood pressure,
respiratory rate and tidal volume.(1,9,10)
In
this study we report our experience in dealing with surgically treated carotid
body tumor with close follow-up in respect to complications, recurrences and
behavior of the tumor.
Methods
The
medical records of 33 patients with 37 surgically treated carotid body tumors between the year 1993 and 2009 at
the Vascular Unit of Queen Alia Military
Hospital and King
Hussein Medical Center
was retrospectively reviewed. Twenty patients were females (60%) and 13 were
males (40%). Their mean age was 46 years
(22-60 years).
All
the patients presented with painless neck mass (Fig. 1). Two patients had hoarseness of voice and
dyspnea, one patient had dysphagia and one had vertigo.
Besides
the clinical diagnosis, duplex ultrasound, angiography, and CT angiography were
used to confirm the diagnosis, to evaluate the extent of the tumor and to check
for bilaterality.
Complete
surgical excision was performed in all our patients with close follow-up in
respect to complications, recurrence and behavior of the tumor.
Surgical
Technique
Excision
of the carotid body tumors is the mainstay of treatment.(3,8,10,12)
Under general endotracheal anesthesia, the neck is explored through an incision
made along the anterior border of sternocleidomastoid muscle. Dissection is
continued to expose the tumor, carotid bifurcation and internal jugular vein (Fig.
2). The posterior belly of the digastrics muscle is separated from the tumor
mass. The common and internal carotid arteries are exposed and a tape is placed
around each for control (Fig. 3). Special care is to be taken to avoid injury
of the cervical branches of the facial, hypoglossal and vagus nerves. A subadventitial plane is developed on the
common carotid artery and the dissection is progressed cephalad (Fig. 3). A
mosquito forceps are introduced and gently opened in the periadventitial plane,
ligating or applying diathermy to the separated vascular tumor tissue and the
adventitia. Ligation of the branches
from the external carotid artery feeding the tumor may decrease tumor’s
vascularity and bleeding during resection.(8,12)
Occasionally,
the external carotid artery may be ligated and divided to facilitate further
resection and decrease intra operative blood loss. If proper plane between the
tumor and the arteries cannot be established due to transmural tumor invasion
of the arterial wall or in cases where the carotid arteries get damaged during
resection of the tumor especially in large sized tumors encasing the vessels (Shamblin
III), carotid arteries resection may be considered and replacement
with
interposition greater saphenous vein graft harvested from the thigh
is applied.(8,12,13) The
preoperative work up including vascular imaging should indicate the likelihood
of vascular involvement and give some indication as to how well the patient
will tolerate temporary internal carotid compromise. Intra operative
neuromonitoring and carotid shunting to prevent hemispheric ischemia are
applied during clamping and reconstruction. A drain is placed and wound closed
after heamostasis is achieved.
Results
All
patients underwent surgical resection with complete excision of their carotid
body tumors achieved. A standard anterior approach to the carotid vessels and
meticulous subadventitial dissection of the tumor were employed. The diagnosis
of carotid body tumor was confirmed histologically in all patients. According
to Shamblin classification, 5 tumors were type I, 22 were type II and 10 were
type III confirmed intra operatively (Table I). Two patients required arterial
reconstruction (Shamblin III tumors) where the external carotid artery was ligated
and interposition vein graft was used to replace the internal carotid artery.
Table I. Distribution of patients according to
Shamblin Classification
Shamblin
|
I
|
II
|
III
|
Patients No
|
5
|
22
|
10
|
The
histological examination showed benign pathology in all but one patient.
Radical neck dissection was done for her 4 years ago with no evidence of
recurrence shown on follow-up.
Four
patients had bilateral involvement at the time of presentation while six had
positive family history of their carotid body tumor.
Transient
neuropraxia of the facial nerve was noticed in one patient, injury of the
recurrent laryngeal nerve in another patient while post operative localized
hematoma had to be evacuated in two patients.
A
mean follow-up period of 24 months (18-60) conducted periodically every 6
months for the first year and then yearly afterwards by clinical assessment,
duplex scan and CT angiography showed a zero operative mortality and no
evidence of recurrence.
Discussion
Von
Haller was the first to describe carotid body tumor in 1743.(6,8) In 1880, Reigner first attempted resection of
carotid body tumor but unfortunately the patient died. Six years later, Maydl
removed successfully the tumor, nevertheless his patient developed stroke. Not
until 1903, when the first successful removal of carotid body tumor was
announced by Scudder.(6,8)
In
1940, Gordon-Taylor demonstrated a safe subadventitial plane for tumor
resection to become the current surgical technique and the procedure that we
used in our patients.(6,10,14)
As
most of the other studies reported, all our patients presented with painless
neck mass located at the angle of the mandible. Carotid body tumors are slow
growing non tender masses that are mobile laterally but vertically fixed due to
their attachment to the carotid bifurcation (Fontaine’s sign).(6,7,15,16)
Because
of its location in close proximity to cranial nerves (X-XII) and cervical
sympathetic chain, progressive enlargement of carotid body tumors occasionally
produce symptoms such as dysphagia, hoarseness of voice, stridor, dysphonia and
Horner’s syndrome.(1,6,8) Two of our patients were noticed to have
hoarseness while one presented with dysphagia.
These symptoms disappeared after surgery as reported by these patients
during their post operative follow-up visits.
Patients
may give history of symptoms suggestive of neuroendocrine activity in less than
5% of tumors such as dizziness, palpitation, tachycardia and hypertension.(1,8,11,17) In these patients, screening for
catecholamine secretion with estimation of urinary metanephrines is indicated
although some authors do routine screening as this neuroendocrine activity
obviously has anesthetic implication.(7,9,11,12) In our patients only those with suggestive
symptoms and signs underwent screening.
Female
predominance has been reported in some studies.
Likewise, we noticed that more than half of our patients with carotid
body tumor were females and most of the tumors become apparent between the
third and sixth decade of life which keeps our results in harmony with the
other studies reports.(6,8,9,18-20)
The published
literature has described the biological behavior of carotid body tumor to be
either sporadic or familial with the former being the commonest.(3,6,11,19,20)
In the familial type (20%),
there is an incidence of bilaterality in
about one third of the patients and a high incidence of multicentricity.(1,4,6,19)
Transmission is by an autosomal dominant pattern inherited due to alteration in
gene coding for succinate dehydrogenase subunit D (SDHD), B (SDHB) and C
(SDHC). The subunits D and B account for a significant percentage of head and
neck paragangliomas.(1,3,11,17) In
our review, six patients (18%) had positive family history and four patients
(12%) had bilateral involvement, two of these were brothers. We believe that
family member screening is strongly recommended in these cases for early
detection and easier resection when discovered at a small tumor size. For
those, Duplex ultrasound scanning was considered the primary diagnostic investigation
in our series.
Investigations
used in our study as in others included: Duplex scan, CT angiogram, magnetic
resonance angiography and conventional angiography.(1,8,11,16,21,22) Duplex with color flow imaging demonstrates
the highly vascularized tumor causing widening of the carotid bifurcation.(10,16)
We used duplex also in all our patients
for post operative follow-up. Both CT and MR scans can reveal the size, extent
and relations of the tumor and help in proper surgical exposure. A slight
superiority of MR noted as it demonstrates the classic “Salt and Pepper”
appearance.(3,8,16) Angiogram remains the gold standard for
the diagnosis and management of carotid body tumor. It shows the tumor blood supply and widening
of the carotid bifurcation by the tumor blush (Lyre sign) which is a pathognomonic
angiographic finding in carotid body tumors.(1,3,13,16,21)
Another advantage of angiography is the possibility for concomitant
embolization to decrease tumor blood supply.(6) Embolization
is still debatable as some authors believe that the response of the tumor makes
subadvantitial plane dissection difficult besides that the procedure may be
complicated by internal carotid artery thrombosis and embolization.(6,7,9,10,12) None of our patients reviewed underwent
embolization for their carotid body tumor beforehand. We used Duplex scan as an
effective modality in making the diagnosis, but angiography and CT or MRI are
helpful to plan surgery.
It
is worth mentioning that incisional biopsy and fine needle aspiration are
contraindicated and should not be included in the
investigations of this highly
vascular
tumor. They may be complicated by massive hemorrhage, false aneurysm and
carotid thrombosis.(8,9,12)
A
surgical classification system was developed by Shamblin et al in 1971
to assess the resectability of these tumor and foretell the surgical morbidity
by dividing the tumors into 3 groups (Fig. 5).
In Group I, tumors are relatively small with minimal attachment to the
carotid vessels and can be easily removed. Group II, tumors are larger with
moderate attachment but separable from adjacent vessels with careful
dissection. Group III, tumors encase carotid arteries and frequently require
arterial reconstruction.(1-3) The majority of the patients
that we studied were classified intra operatively as having Shamblin II (Table
I). Two patients with Shamblin III required arterial reconstruction to achieve
complete excision of the tumor. Some authors have stated that carotid body
tumor cannot be classified preoperatively but Aryl et al have
illustrated that pre operative MR imaging can predict Shamblin group using the
degree of circumferential contact of the carotid body tumor with the internal
carotid artery on axial images.(3,21)
As
demonstrated by most other studies, carotid body tumor mostly exhibits benign
characteristics with less than 10% being malignant.(5,17,23) Malignant potentials cannot be predicted by
histological markers and can only be assumed in the presence of lymph nodes or
distal metastasis.(3,6,8,11,23) So the histological appearance of a carotid body tumor
is not a reliable guide to its propensity for malignant behavior. One of our patients demonstrated
localized lymph node involvement. She underwent neck dissection and has been on
follow-up for the last four years with no recurrence up to date.
In
our study, two patients were from Yemen where they live at about 2200
meters above sea level. High altitude with chronic hypoxic states were
considered as proposed risk factors for carotid body hyperplasia in some other
studies.(10,19,24,25)
Although there is a general agreement that complete surgical excision is
the best treatment option, a more conservative approach is occasionally justified.(12)
Patients may be managed non-surgically, as advocated by some authors because of
age and concomitant atheromatous disease of the contralateral carotid vessels
as the risks of operation in these patients are judged to be high. Radiotherapy
has been used as an alternative treatment in high-risk patients and in the
occasional cases where the tumor is inoperable, large or recurrent.(5,9,26-28) In our series, all the patients were operated
successfully achieving complete surgical excision since all the patients were
in shape for surgery and anesthesia.
Though the current surgical techniques have reduced the post operative
complications especially stroke rate, the incidence of cranial nerves injury
remains relatively high ranging between 20-40%.(8,13,23) Most
of these cranial nerve injuries are temporary. The incidence of permanent
cranial nerve deficit has been quoted less than 1% in international literature.(14,19)
Transient neuropraxia of the facial
nerve was noticed in one of our patients (3%) and another patient had injury of
his recurrent laryngeal nerve (3%) which were diagnosed on clinical basis and
neurological examination / laryngoscopy. To minimize the risk of complications,
we advocated subadventitial dissection at an early stage when the tumor
excision can be carried out with less bleeding and with a clearer operative
field. No recurrences were reported in our series but we believe that continued
follow-up is required as recurrences and metastasis may occur years after the
initial diagnosis.(3,5,11)
Conclusion
Carotid body tumors are rare but the diagnosis should be kept in mind in
any patient presenting with a neck mass in the anterior triangle of the neck.
Both sides of the neck need to be investigated to detect bilateral tumors.
Misdiagnosed patients may undergo unnecessary procedures, which could be
disastrous. Complete
surgical excision after adequate investigations is the treatment of choice. In order to obtain good results; these tumors should be dealt with in
a specialized center, where the availability of an experienced team who is familiar
with carotid surgery improves the chances for a more successful outcome in
these patients.
References
1. Garcia MA, Pendas JL,
Tapia JPR, et al. Head and neck paragangliomas: revision of 89
cases in 73 patients. Acta Otorrinolaringol Esp 2007; 58(3): 94-100.
2. Lee KY, Oh YW, Noh HJ, et al. Extraadrenal paragangliomas
of the body: imaging features. American Journal of Roentgenology 2006;
187:492-504.
3. Wieneke JA, Smith A. Paraganglioma: carotid
body tumor. Head and Neck Pathol 2009; 3:303-306.
4. Netterville JL, Jackson CG, Miller
FR, et al.
Vagal paraganglioma: a review of 46 patients treated during a 20-year
period. Arch Otolaryngol Head Neck Surg 1998; 124:1133-1140.
5. Lee JH, Barich F,
Karnell LH, et al.
National cancer data base report on malignant paragangliomas of the head and
neck. Cancer 2002; 94:730-737.
6.Albsoul NM, Alsmady MM, Al-Aardah MI, et al.
Carotid
body paraganglioma management and outcome. European Journal of Scientific
Research 2009; 37(4):567-574.
7. Attia AA, Abdallah H, Mamoun S, et al. Carotid
Body Paragangliomas. Journal of the Egyptian National Cancer Institute. 2001;13(2):79-84.
8. Davidovic LB, Djukic VB, Vasic DM, et al.
Diagnosis
and treatment of carotid body paraganglioma: 21 years of experience at a
clinical center of Serbia. World Journal of Surgical Oncology 2005; 3:10.
9.Rekha A, Ravi A, Vijayaraghavan KS. Paraganglioma neck – a
neuroendocrine tumor revisited. Int J Angiol 2008; 17(3):162-165.
10. Atefi S, Nikeghbalian S, Yarmohammadi H, et al. Surgical management of carotid body
tumors: a 24 year surgical experience. ANZ J Surg 2006; 76(4): 214-217.
11. Mathew BK, Bandgar T, Menon PS, Shah NS Carotid body tumors: three case reports.
Singapore
Med J 2009; 50(2):58-60.
12.Singh D, Pinjala RK, Reddy RC, et al.. Management
for carotid body paragangliomas. Inter Cardio Thorc Surg 2006; 5:692-695.
13. Anand VK, Alemar GO, Sanders TS. Management of the internal carotid artery during carotid body tumor
surgery. Laryngoscope 1995; 105:231-235.
14. Plukker JT, Brongers EP, Vermey A, et al. Outcome of surgical treatment for carotid body paraganglioma. Br J
Surg 2001; 88(10):1382-1386.
15. Jansen JC, van den
Berg R, Kuiper A, et al. Estimation of growth
rate in patients with head and neck paragangliomas influences the treatment
proposal. Cancer 2000; 88:2811-2816.
16. Stoeckli SJ, Schuknecht
B, Alkadhi H, et al. Evaluation of paragangliomas presenting as a cervical mass on color-coded Doppler
sonography. Laryngoscope 2002; 112:143-146.
17. Boedeker
CC, Neumann HP, Maier W, et al. Malignant head and neck paragangliomas in SDHB mutation
carriers. Otolaryngol Head Neck Surg 2007; 137:126-129.
18. Luna-Ortiz
K, Rascon-Ortiz M, Villavicencio-Valencia V, et al. Carotid body tumors: review of a 20-year
experience. Oral Oncol 2005; 41:56-61.
19. Sajid MS,
Hamilton G, Baker DM. A Multicenter Review of Carotid Body Tumour
Management. Eur J Vasc Endovasc Surg 2007; 34: 127-130.
20. Lim
JY, Kim SH, Lee S, et al. Surgical treatment of carotid body
paragangliomas: outcomes and complications according to the shamblin
classification. Clin Exp
Otorhinolaryngol 2010; 3(2):91-95.
21. Arya S,
Rao V, Juvekar S, et al. Carotid Body Tumors: Objective Criteria to
Predict the Shamblin Group on MR Imaging. American Journal of Neuroradiology
2008; 29:1349-1354.
22.Pacheco-Ojeda
LA, Martinez-Viteri MA. Preoperative imaging diagnosis of
carotid body tumors. International Surgery 2010; 95(3): 242-246.
23. Hallett Jr JW, Nora JD, Hollier LH, et
al. Trends in neurovascular
complications of surgical management for carotid body and cervical paragangliomas:
a fifty-year experience with 153 tumors. J Vasc Surg 1988; 7:284-291.
24. Saldana MJ, Salen LE, Travesan R. High altitude hypoxia and chemodectomas. Hum Path 1973; 4:
251-63.
25. Cerecer Gil NY, Figuera LE, Liamas FJ, et al.
Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma. Clinical
Cancer Research 2010; 16(16):4148-54.
26.Patetsios P, Gable DR, Garrett WV, et al. Management of carotid body paragangliomas and review of a 30 year
experience. Ann Vasc Surg 2002; 16(3): 331-338.
27. Rao AB, Koeller KK, Adair CF. Paragangliomas
of the head and neck: Radiologic-pathologic correlation. Radiographics 1999;
19(6): 1605-1632.
28. Cengiz
M, Ozyigit G, Yazici G, et al. Salvage reirradiaton with
stereotactic body radiotherapy for locally recurrent head - and - neck tumors. International
Journal of Radiation Oncology, Biology, Physics 2010 Jul 31.